MicroRNA-212/ABCG2-axis contributes to development of imatinib-resistance in leukemic cells

BCR-ABL-independent resistance against tyrosine kinase inhibitor is an emerging problem in therapy of chronic myeloid leukemia. Such drug resistance can be linked to dysregulation of ATP-binding cassette (ABC)-transporters leading to increased tyrosine kinase inhibitor efflux, potentially caused by...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaehler, Meike, Ruemenapp, Johanna, Gonnermann, Daniel, Nagel, Inga, Bruhn, Oliver, Haenisch, Sierk, Ammerpohl, Ole, Wesch, Daniela, Cascorbi, Ingolf, Bruckmueller, Henrike
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5696160/
https://www.ncbi.nlm.nih.gov/pubmed/29190894
http://dx.doi.org/10.18632/oncotarget.21272

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5696160/
https://www.ncbi.nlm.nih.gov/pubmed/29190894
http://dx.doi.org/10.18632/oncotarget.21272

Ejemplares similares